>

>

The MDR Technical File Challenge: An Executive Brief

The MDR Technical File Challenge: An Executive Brief

The MDR Technical File Challenge: An Executive Brief

Technical Documentation

Obodux Team

Obodux cover graphic: The MDR Technical File Challenge executive brief

The compliance crisis

The EU Medical Device Regulation (MDR) has created a perfect storm for medical device manufacturers:

  • Technical file preparation costs increased 40–60% compared with the previous MDD framework

  • Review timelines extended to 6–18 months due to Notified Body capacity constraints

  • Up to 70% of submissions receive major nonconformities in the first review round

  • The three-strike system means manufacturers have just three chances to get it right before facing costly rejection

For many manufacturers, traditional documentation approaches simply cannot meet these demands.

Understanding the stakes

The Notified Body reality

Once a technical file enters formal review, manufacturers face a structured three-round evaluation process:

  • Round 1: initial assessment identifies gaps and deficiencies

  • Round 2: review of manufacturer corrections and responses

  • Round 3: final opportunity to resolve remaining issues

After three strikes, the application is rejected. Manufacturers must resubmit from scratch, paying new fees and returning to the back of the queue, a process that can delay market access by a year or more.

Even before formal review, pre-checks reject incomplete submissions, adding 8–12 weeks to timelines.

The cost of inadequate preparation

Direct costs per additional review round

  • Notified Body fees: €15,000–30,000

  • Internal response preparation: €20,000–40,000

  • External consultant support: €10,000–25,000

Application rejection costs

  • Lost application fees: €50,000–100,000

  • Resubmission fees: €50,000–150,000

  • Lost revenue from a 6–18 month delay: potentially millions

Indirect costs

  • Damaged reputation with Notified Bodies

  • Lost competitive positioning

  • Resources diverted from innovation

  • Reduced investor confidence

The seven critical challenges

1. Skyrocketing costs

Resource-intensive documentation, specialist expertise requirements and infrastructure investment have dramatically increased compliance budgets, which is particularly challenging for SMEs without in-house regulatory teams.

2. Unpredictable delays

Iterative reviews between teams, data dependencies from testing and clinical evaluation, and Notified Body backlogs make timelines impossible to predict with traditional approaches.

3. Regulatory ambiguity

Vague requirements, inconsistent Notified Body interpretations and evolving guidance create uncertainty about what constitutes "sufficient" evidence or "adequate" documentation.

4. Documentation complexity

Technical files integrate design controls, risk management, clinical evaluation, labelling and post-market surveillance into a large, interdependent web of evidence that requires impeccable traceability.

5. Expertise gaps

Shortages of regulatory specialists, knowledge silos between teams and heavy training burdens leave manufacturers struggling to maintain the necessary competencies.

6. External dependencies

Reliance on contractors for clinical evaluation, testing or documentation creates coordination challenges, quality variability and timeline risks.

7. Notified Body constraints

Limited availability, inconsistent interpretations, audit readiness demands and costly nonconformities make the Notified Body relationship challenging.

Why traditional approaches fail

Manual, document-based technical file creation has serious limitations:

Version control problems

  • Relies on naming conventions and human discipline

  • Cross-references become outdated with each revision

  • Change impact assessment is manual and error-prone

Collaboration friction

  • Information scattered across email chains and shared drives

  • No real-time visibility into documentation status

  • Difficult coordination across teams and locations

Traceability breakdown

  • Spreadsheet matrices quickly become unmanageable

  • No automation of requirement linkages

  • Audit trail limited or absent

Quality risks

  • Inconsistent terminology and formatting

  • Missing or incomplete sections discovered late

  • Limited validation of completeness

The result is files that take too long to prepare, contain too many errors and require too many review cycles, exactly the opposite of what MDR demands. Our article on the hidden risk killing your MDR approval looks at this in more detail.

The digital transformation solution

Purpose-built SaaS platforms for technical file creation offer capabilities that manual processes cannot match.

Structured data management

  • Technical file content as searchable, structured data

  • Automated cross-referencing eliminates inconsistencies

  • Single source of truth with complete audit trail

Intelligent automation

  • Auto-generation of standard sections and summaries

  • Automated traceability matrix creation and maintenance

  • Validation of completeness and consistency

  • Document assembly for submission

Collaborative workflows

  • Real-time collaboration across distributed teams

  • Built-in review and approval workflows

  • Role-based access and permissions

  • Integrated task and notification management

Regulatory intelligence

  • Pre-configured MDR Annex II and III templates

  • Integration of harmonised standards requirements

  • Notified Body-specific submission formats

  • Continuous updates as guidance evolves

Lifecycle management

  • Change control with automated impact assessment

  • Post-market surveillance integration

  • Design change management

  • Supplier and component tracking

Measured impact

Organisations implementing digital solutions report:

  • Time savings: 40–60% reduction in documentation preparation time, 70% faster Notified Body question responses and 50% reduction in information retrieval time

  • Quality improvements: 80% reduction in cross-reference errors, 60% fewer first-round nonconformities and 50% reduction in internal review cycles

  • Cost reduction: 30–40% lower overall preparation costs, 50% reduction in external consultant requirements and 40% fewer Notified Body review cycles

Strategic imperatives for success

1. Invest in preparation, not remediation

Quality upfront work costs far less than correcting deficiencies during review. Start documentation early, plan comprehensively and use expertise from the beginning.

2. Implement robust document control

Version control and traceability are non-negotiable. Use purpose-built tools, establish clear standards and maintain rigorous discipline.

3. Build cross-functional collaboration

Break down silos between regulatory, quality, clinical and engineering teams. Create shared understanding and make communication easy.

4. Conduct thorough internal reviews

Don't make the Notified Body your first reviewer. Perform mock audits, peer reviews and checklist-based validations before submission.

5. Embrace digital tools

Manual processes cannot scale to MDR complexity. Select and implement platforms purpose-built for technical file creation.

6. Commit to continuous improvement

Learn from experience, stay current with regulatory developments and evolve capabilities over time.

The competitive advantage

While MDR compliance presents significant challenges, it also creates opportunities for differentiation. Manufacturers that master technical file creation gain:

  • Faster time to market: streamlined documentation processes, fewer review cycles and predictable timelines

  • Lower costs: reduced external dependencies, fewer nonconformities and less rework

  • Reduced risk: better documentation quality and consistency, audit readiness and regulatory defensibility

  • Strategic capability: the ability to manage larger product portfolios and a foundation for lifecycle management

Take the next step

The manufacturers succeeding under MDR treat technical file excellence as strategic, invest in purpose-built digital tools, integrate documentation with product development, collaborate across functions and commit to continuous improvement.

The question isn't whether to digitise technical file creation, but when.

  1. Assess your current technical file capabilities and challenges

  2. Define what success looks like for your organisation

  3. Explore digital solutions purpose-built for MDR compliance

  4. Pilot with real projects to validate capabilities

  5. Implement strategically with proper training and change management

See how Obodux structures MDR and IVDR technical documentation, or start a 4-week free trial. For the structure itself, read EU MDR Technical File: Structure It Once, Maintain It Properly.

This brief is provided for informational purposes only and does not constitute regulatory or legal advice.

Ready to structure your technical documentation?

Ready to structure your technical documentation?

Obodux is a SaaS platform that streamlines medical device compliance. Using AI tools and a secure workspace, it helps prepare CE, UKCA, and global documentation faster, stay audit-ready, and launch products confidently.

Compliance Disclaimer: Obodux provides tools to assist with regulatory compliance but does not guarantee regulatory approval. Users remain responsible for ensuring their compliance with applicable regulations.

Cyber Essentials   Certified

© 2026 Obodux. All rights reserved. Obodux is the MedTech compliance product from BORIS Software Ltd.

Obodux is a SaaS platform that streamlines medical device compliance. Using AI tools and a secure workspace, it helps prepare CE, UKCA, and global documentation faster, stay audit-ready, and launch products confidently.

Compliance Disclaimer: Obodux provides tools to assist with regulatory compliance but does not guarantee regulatory approval. Users remain responsible for ensuring their compliance with applicable regulations.

Cyber Essentials   Certified

© 2026 Obodux. All rights reserved. Obodux is the MedTech compliance product from BORIS Software Ltd.

Obodux is a SaaS platform that streamlines medical device compliance. Using AI tools and a secure workspace, it helps prepare CE, UKCA, and global documentation faster, stay audit-ready, and launch products confidently.

Compliance Disclaimer: Obodux provides tools to assist with regulatory compliance but does not guarantee regulatory approval. Users remain responsible for ensuring their compliance with applicable regulations.

Cyber Essentials   Certified

© 2026 Obodux. All rights reserved. Obodux is the MedTech compliance product from BORIS Software Ltd.